Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quanduzhong Capsule for essential hypertension
ChiCTR1900021699Phase 4Recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Jun 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in essential hypertension comparing Quanduzhong Capsule with Placebo (2 arms). Primary endpoint: 24-hour ambulatory blood pressure. Started Jun 2018; status: recruiting.
02
Drugs
Quanduzhong
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR1900021699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021699.